Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2831)
All Articles published online
|
Aug 7, 2008 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gao YF, Yu L, Wei W, Li JB, Luo QL, Shen JL. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA. World J Gastroenterol 2008; 14(29): 4684-4689 [PMID: 18698684 DOI: 10.3748/wjg.14.4684] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i29/4684.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Pranjal Yadava, Sunil Kumar Mukherjee. Regulatory RNAs. 2012; : 505 doi: 10.1007/978-3-642-22517-8_20
|
| 3 |
Nattanan Panjaworayan, Chris M. Brown. Effects of HBV Genetic Variability on RNAi Strategies. Hepatitis Research and Treatment 2011; 2011: 1 doi: 10.1155/2011/367908
|
| 4 |
Wei Hu, Ting Li, Mu Li, Lei Wu, Xingyu Meng, Yuhua Tian. Effects of microRNA-mediated IGF-1 gene silencing on telomerase activity and cell proliferation in deer antler cells. Canadian Journal of Animal Science 2014; 94(3): 417 doi: 10.4141/cjas2013-050
|
| 5 |
Cheng-Guo Duan, Chun-Han Wang, Hui-Shan Guo. Application of RNA silencing to plant disease resistance. Silence 2012; 3(1) doi: 10.1186/1758-907X-3-5
|
| 6 |
Douglas Mogul, Michael Torbenson, Kathleen B. Schwarz. Epigenetic Regulation of Hepatitis B Virus Infection. Current Hepatitis Reports 2011; 10(4): 277 doi: 10.1007/s11901-011-0113-3
|
| 7 |
Jiang Li, Jianqin Lu, Yifei Zhang, Mohammed Ghazwani, Peng Zhang, Xiang Gao, Song Li. Advanced Delivery and Therapeutic Applications of RNAi. 2013; : 327 doi: 10.1002/9781118610749.ch15
|
| 8 |
Gang Li, Xiaojia Xiong. MicroRNAs and hepatitis viruses. Frontiers of Medicine in China 2009; 3(3): 265 doi: 10.1007/s11684-009-0055-0
|
| 9 |
Maged Gomaa Hemida, Xin Ye, Simone Thair, Decheng Yang. Exploiting the Therapeutic Potential of MicroRNAs in Viral Diseases. Molecular Diagnosis & Therapy 2010; 14(5): 271 doi: 10.1007/BF03256383
|
| 10 |
Anna Kotowska‐Zimmer, Marianna Pewinska, Marta Olejniczak. Artificial miRNAs as therapeutic tools: Challenges and opportunities. WIREs RNA 2021; 12(4) doi: 10.1002/wrna.1640
|
| 11 |
Pranjal Yadava, Sunil Kumar Mukherjee. Regulatory RNAs. 2012; : 505 doi: 10.1007/978-3-642-22517-8_20
|
| 12 |
Ailbhe M. McDermott, Helen M. Heneghan, Nicola Miller, Michael J. Kerin. The Therapeutic Potential of MicroRNAs: Disease Modulators and Drug Targets. Pharmaceutical Research 2011; 28(12): 3016 doi: 10.1007/s11095-011-0550-2
|
| 13 |
Raquel Calloni, Diego Bonatto. Scaffolds for Artificial miRNA Expression in Animal Cells. Human Gene Therapy Methods 2015; 26(5): 162 doi: 10.1089/hgtb.2015.043
|
| 14 |
Junzheng Du, Shandian Gao, Jihuai Luo, Guofeng Zhang, Guozheng Cong, Junjun Shao, Tong Lin, Xuepeng Cai, Huiyun Chang. Effective inhibition of foot-and-mouth disease virus (FMDV) replication in vitro by vector-delivered microRNAs targeting the 3D gene. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-292
|
| 15 |
Tingfan Zhu, Jinhan Qian, Zijun Shen, Hongxia Shao, Kun Qian, Wenjie Jin, Aijian Qin. Vector-delivered artificial miRNA effectively inhibits Porcine epidemic diarrhea virus replication. Virology Journal 2023; 20(1) doi: 10.1186/s12985-023-02129-5
|
| 16 |
Yingying Mao, Xuejun Wang, Wei Hu, Andrew Li, Ying Li, Hai Huang, Renhe Yan, Yanling Zhang, Jinlong Li, Hongwei Li, Shengqi Wang. Long-term and efficient inhibition of hepatitis B virus replication by AAV8-delivered artificial microRNAs. Antiviral Research 2022; 204: 105366 doi: 10.1016/j.antiviral.2022.105366
|
| 17 |
Lili Guo, Xiang Yang, Tao Duan. Altered microRNA expression profile in maternal and fetal liver of HBV transgenic mouse model. The Journal of Maternal-Fetal & Neonatal Medicine 2012; 25(10): 2071 doi: 10.3109/14767058.2012.678431
|
| 18 |
Chun-Mei Wang, Yan Wang, Chun-Guang Fan, Fei-Fei Xu, Wen-Sheng Sun, Yu-Gang Liu, Ji-Hui Jia. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2011; 411(3): 586 doi: 10.1016/j.bbrc.2011.06.191
|
| 19 |
|